surmount-1 tirzepatide trial obesity without diabetes SURMOUNT-4 results just published in @JAMA_current 🛑Stopping #tirzepatide leads to regain of the majority of the lost weight. Is this a surprising result ⁉️ No #Obesity is a chronic disease and requires SURMOUNT 1 // Three-Year Obesty

The hair loss associated with GLP-1 medications is typically telogen effluvium, a temporary shedding condition triggered by rapid weight loss, caloric restriction, and nutritional changes rather than the medication itself

Brand-name tirzepatide is expensive

Indeed, a phase 2 mechanistic trial (NCT05936151) investigating change in eGFR from baseline to week 24 with multiple doses of retatrutide vs

These mechanisms complement GLP-1 effects through different neural and hormonal pathways, creating a more comprehensive appetite suppression signal than GLP-1 alone

so as you lose weight, we can see what source

This complete guide breaks down the tirzepatide vs semaglutide comparison using the latest 2026 clinical data, real costs, and side effect profiles